BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Ligand Pharmaceuticals

Ligand is an emerging specialty pharmaceutical company that discovers, develops and markets innovative small molecule drugs to address critical, unmet medical needs. Ligand markets four oncology and dermatology products in the United States – ONTAK®, Targretin® capsules, Targretin® gel and Panretin® gel. Ligand launched its fifth product, AVINZA™, a treatment for chronic, moderate-to-severe pain, in the second quarter of this year. In addition, Ligand's network of major pharmaceutical partners is developing products for men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's robust R&D pipeline is based on the company's leadership in gene transcription technology.


Contact Details:
10275 Science Center Drive
San Diego
CA
92121-1117
United States of America
Tel:858 550 7500
Fax:858 550 7506
Email:investors@ligand.com
WWW:

www.ligand.com/




Loading...

Recent Publications by Ligand Pharmaceuticals:

Discovery of a novel series of nonsteroidal androgen receptor modulators: 5- or 6-oxachrysen-2-ones.
A novel oxachrysenone series (2) of nonsteroidal selective androgen...
10th July, 2008
Discovery Research, Ligand Pharmaceuticals Inc., 10275 Science Center Bioorg Med Chem Lett. 2008 Jun 1;18(11):3431-5. Epub 2008 Apr 8.
DOI Direct Link
A Tissue-Selective Nonsteroidal Progesterone Receptor Modulator: 7,9-Difluoro-5-(3-methylcyclohex-2-enyl)-2,2,4-trimethyl-1,2-dihydrochrome no[3,4-f]quinoline.
The progesterone receptor plays an important role in the female...
17th June, 2008
Discovery Research, Ligand Pharmaceuticals Inc., 10275 Science Center J Med Chem. 2008 Jul 10;51(13):3696-9. Epub 2008 Jun 14.
DOI Direct Link
LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo.
Treatment of inflammation is often accomplished through the use of...
11th June, 2008
Discovery Research, Ligand Pharmaceuticals, San Diego, California 92121, Endocrinology. 2008 May;149(5):2080-9. Epub 2008 Jan 24.
DOI Direct Link
Discovery of structurally diverse nonsteroidal SPRMs based on a screening hit, 1,2-dihydro-2,2,4-trimethyl-6-phenylquinolinone.
Synthetic steroidal progestins and antiprogestins have been widely used...
10th June, 2008
Discovery Research, Ligand Pharmaceuticals Inc., 10275 Science Center Curr Top Med Chem. 2008;8(9):766-80.
Recent developments in the discovery of selective glucocorticoid receptor modulators (SGRMs).
Steroidal glucocorticoids are widely prescribed for the treatment of a...
10th June, 2008
Discovery Research, Ligand Pharmaceuticals, 10275 Science Center Drive, Curr Top Med Chem. 2008;8(9):750-65.

View more Ligand Pharmaceuticals research publications.

BioNews Results for Ligand Pharmaceuticals:

APS 2008: Balancing Access and Risk in Acute Pain Management
Medscape:  Jul 3 2008 4:20PM Matching: ligand pharmaceuticals
MDS Pharma Services Names Dr. Lori McDonald to Executive Leadership Team
Healthcare Sales & Marketing Network:  Jun 27 2008 4:09AM Matching: ligand pharmaceuticals
MDS Pharma Services Names Dr. Lori McDonald to Executive Leadership Team
Citybizlist:  Jun 26 2008 9:11PM Matching: ligand pharmaceuticals
MDS Pharma Services Names Dr. Lori McDonald to Executive Leadership Team
SmartBrief:  Jun 26 2008 5:16PM Matching: ligand pharmaceuticals
MDS Pharma Services Names Dr. Lori McDonald to
Citybizlist:  Jun 26 2008 5:13PM Matching: ligand pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution

View more Ligand Pharmaceuticals news.

Ligand Pharmaceuticals Patents:

US Patent No.Title
6444668 Combination regimens using progesterone receptor modulators
6566372 Bicyclic androgen and progesterone receptor modulator compounds and methods
6576676 Means for the modulation of processes mediated by retinold receptors and compounds useful therefor
6583145 Thio-oxindole derivatives
6593493 RXR modulators with improved pharmacologic profile

View more Ligand Pharmaceuticals patents.

Ligand Pharmaceuticals (LGND) Financial information Links from Barchart

LGND Quote from from Barchart.com
LGND Chart from from Barchart.com
LGND Profile from from Barchart.com
LGND Opinion from from Barchart.com

View more Ligand Pharmaceuticals finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 42 individuals from Ligand Pharmaceuticals using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 487 times since April 2007, the link to the organisation's website has been followed 89 times

Recent Search Terms used to find this page: Ligand pharmaceuticals | pharmaceutical san diego | targretin | oxachrysenone | Ligand Pharma and San Diego | Ligand Pharmaceuticals Contacts | Discovery Research, Ligand Pharmaceuticals | Discovery Research Ligand Pharmaceuticals | Ligand Pharmaceuticals 10275 Science Center Dr | Discovery Research Ligand Pharmaceuticals | .

Search for more companies in San Diego

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Ligand Pharmaceuticals
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.